Parkinson's News Today Home | Parkinson's News Today
5 days ago · New tool could show how genetic variants raise Parkinson’s risk. A new screening method may shed light on the interactions between genetic variants that increase the risk of Parkinson’s disease, providing potential avenues for improving risk prediction and personalized care, a study found.
HHS Announces Progress on Establishing the National Parkinson…
2 days ago · Today, U.S. Department of Health and Human Services Secretary Xavier Becerra announced he would delegate the authority vested in the HHS under the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act to the National Institutes of Health, with support from the HHS Office of the Assistant Secretary for Health.
What's New in Parkinson's - Davis Phinney Foundation
Dec 31, 2024 · The final 2024 edition of What’s New in Parkinson’s features a special year-end review of five of the most significant news highlights from 2024 and a handful of the most important publications from December 2024. Two important new treatments were approved for Parkinson’s in 2024.
Parkinson's News -- ScienceDaily
4 days ago · Information on Parkinson's disease. Learn about Parkinson's disease treatments, symptoms, new research and medication.
Top Parkinson’s Science News Articles of 2024
Dec 10, 2024 · Our Science News article series highlight exciting Parkinson’s studies and how they impact those living with this disease. Explore our top Science News articles of 2024 below: 1. A Skin Test Could Detect Parkinson’s and Related Diseases.
A Potential Parkinson’s Treatment Has Promising Results
Jun 20, 2024 · A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment...
FDA Approves New Treatment for Advanced Parkinson’s Disease
Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help...
Parkinson's disease - Latest research and news - Nature
3 days ago · Parkinson's disease is a progressive neurodegenerative disorder, which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Motor symptoms...
New Vaccine for Parkinson’s Moves Closer to 1st Human Trials
Dec 1, 2022 · An experimental vaccine that stimulates immune responses against three regions of the alpha-synuclein protein — whose toxic clumps contribute to Parkinson’s disease and dementia with Lewy bodies (DLB) — is moving into late-stage preclinical research aimed at supporting future requests to test it in clinical trials.
Parkinson's vaccine seen to target toxic protein in Phase 1 trial
Mar 11, 2024 · Treatment with UB-312, a vaccine designed to trigger an immune response against toxic clumps of the alpha-synuclein protein, reduced these damaging aggregations in people with Parkinson’s disease in a Phase 1 trial.